High Response Seen for Chemo in Seniors With High-Risk AML
THURSDAY, June 20, 2019 -- A substantial proportion of older patients with high-risk acute myeloid leukemia (AML) treated with chemotherapy are long-term survivors, according to research published online June 7 in Cancer Medicine.
Sarah Bertoli,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Leukemia | Pharmaceuticals